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Which blastocysts should be considered for genetic screening? 1 
 2 
Given the exciting rapid evolution of genetic technology we, 3 
along with many others, are contemplating the idea of 4 
preimplantation genetic screening of all blastocysts. In this 5 
context we were interested in the recent paper by Fiorentino et 6 
al., 2014). They reported on the application of both array-7 
comparative genomic hydridization (CGH) and next generation 8 
sequencing (NGS) using instrumentation from Illumina, Inc. 9 
They showed 99.5% concordance between the 2 technologies 10 
and 38.5% of embryos having trophectoderm biopsy proved 11 
euploid. Following the transfer of 50 screened embryos in 47 12 
women, they had 32 clinical implantations (64.0%) with all 13 
those cases proceeding to livebirths. 14 
 15 
Before expending the rather large financial outlay in setting up 16 
similar technology in our own facility, we would like to initiate 17 
a debate by presenting data showing that morphological 18 
assessment of blastocysts can provide similar high implantation 19 
rates. Our data, which is supplemental to a larger study (Yovich 20 
et al, 2015), questions the relevance of applying the advanced 21 
genetics in facilities that already have high implantation rates. 22 
 23 
Table 1 shows the implantation rates from 529 single embryo 24 
transfers in a hormone controlled cycle where vitrified embryos 25 
were warmed utilising the Cryotop method (Kuwayama et al, 26 
2005). It can be seen that those embryos graded 4AA or 5AA on 27 
morphological criteria implant at 63-65% level; i.e. equivalent 28 
to the genetically screened embryos reported by Fiorentino et al. 29 
Figure 1 shows the regression line for blastocysts of all 30 
gradings, indicating that there is a reliable predictive value in 31 
these gradings (R
2
 = 0.9715). Perhaps only those embryos 32 
graded in the Modest to Medium groupings should be 33 
considered for genetic screening. Blastocysts categorised in the 34 
High group and Top groups will not benefit from screening as 35 




Clinical pregnancies and livebirths according to blastocyst grading categorized from lowest to highest pregnancy rate 
following single embryo transfer. The blastocyst groups are categorized according to implantation rates. (CP, clinical 














30 to 39% 
Medium group 
40 to 49% 
High group 
50 to 59% 
Top group 
60 to 69% 
 
#CP 0 0 0 13 4 8 2 10 6 13 12 46 24 41 37 55 271 
# 
Transfers 
2 2 2 41 12 22 5 23 13 28 25 89 45 76 59 85 529 
PR 0% 0% 0% 32% 33% 36% 40% 43% 46% 46% 48% 52% 53% 54% 63% 65% 51% 
# LB 0 0 0 10 1 5 1 8 2 6 7 36 19 32 31 47 205 


























Blastocyst gradings applying Ga rdner criteria
Figure 1 
Pregnancy rate from single vitrified blastocyst transfer according to post-warm blastocyst grading 
at time of transfer, categorised from lowest to highest implantation ratings. Three groups excluded 
with no pregnancies from 6 transfers – hatched blastocysts 6BB, 6BA and 6AB 
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